Evidence map›Paper›PMID 30949889›Full record

ArticleEuropean journal of pediatrics2019

Are antibiotics a risk factor for the development of necrotizing enterocolitis-case-control retrospective study.

Ali Ahmed Raba, Anne O'Sullivan, Jana Semberova, Aisling Martin, Jan Miletin

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of pediatrics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 4 pooled it
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 4 syntheses or guidelines pooled it, 36 citations in OpenAlex.

  1. Risk factors for necrotizing enterocolitis in preterm infants: a Meta analysis.Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2022
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Nanomedicine to fight infectious disease.Advanced drug delivery reviews · 2021
    Review
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Ali Ahmed RabaSchool of Medicine, National University of Ireland, Galway, Ireland.
Anne O'SullivanDepartment of Neonatology, Coombe Women and Infants University Hospital, Cork Street, Dublin 8, Ireland.
Jana SemberovaDepartment of Neonatology, Coombe Women and Infants University Hospital, Cork Street, Dublin 8, Ireland.
Aisling MartinDepartment of Neonatology, Coombe Women and Infants University Hospital, Cork Street, Dublin 8, Ireland.
Jan MiletinDepartment of Neonatology, Coombe Women and Infants University Hospital, Cork Street, Dublin 8, Ireland. miletinj@yahoo.com.
Coombe Women & Infants University Hospital · IEUniversity College Dublin · IEÚstav pro Péči o Matku a Dítě · CZ

Funding

Seventh Framework Programme 260777
6 · The paper itself

Abstract

Previous studies have identified numerous risk factors associated with necrotizing enterocolitis (NEC) in very low birth weight (VLBW; birth weight less than 1500 g) infants. One of the potential pathophysiological contributors could be antibiotic therapy. Our aim was to explore the association between antibiotic exposure and NEC in VLBW infants. We designed a retrospective 1:2 case-control cohort study in a level III neonatal intensive care unit. Our study group composed of VLBW infants born between January 2012 and December 2014 with a diagnosis of NEC stage IIA or greater (Bell's modified criteria). Our intent was to match every case in the study group to two controls. Our primary outcome was an association between antibiotic exposure and NEC. Twenty-two cases of NEC were matched to 32 controls. The infants who developed NEC were exposed to a statistically significantly more frequent number of antibiotic courses and to more days on any antibiotic prior to the development of NEC. There were significant differences between cases and controls with respect to the duration of exposure to gentamicin and meropenem specifically.Conclusion: The data from our study demonstrate that prolonged exposure to antibiotic therapy is associated with an increased risk of NEC among VLBW infants. Furthermore, gentamicin and meropenem, but not other antibiotics, had a significant association with the incidence of NEC. What is known: • Early antibiotic exposure is a risk factor for the development of necrotising enterocolitis (NEC) in very low birth weight infants • Prolonged initial empirical antibiotic course for ≥ 5 days, despite sterile blood culture, is associated with an increased risk of developing NEC What is new: • The cumulative total number of days of antibiotic exposure is associated with an increased risk of developing NEC • Gentamicin and meropenem, but not other antibiotics, had a significant association with the incidence of NEC in our study.

Indexed as

Anti-Bacterial AgentsCase-Control StudiesEnterocolitis, NecrotizingFemaleGentamicinsHumansInfant, NewbornInfant, Very Low Birth WeightIntensive Care Units, NeonatalMeropenemRetrospective StudiesRisk FactorsAnti-Bacterial AgentsGentamicinsMeropenemAntibioticsCase-control studyNecrotising enterocolitisVery-low-birth-weight infant

Identifiers

PMID30949889
OpenAlexW2929664912

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.